• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于胃癌风险分层模型鉴别癌前病变与胃炎

Discrimination between Precancerous Gastric Lesions and Gastritis Using a Gastric Cancer Risk Stratification Model.

机构信息

University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Department of Epidemiology, Chapel Hill, NC, USA.

Duke University, Department of Population Health Sciences, and Duke Cancer Institute, Cancer Risk, Detection, and Interception Program, Durham, NC, USA.

出版信息

Asian Pac J Cancer Prev. 2023 Mar 1;24(3):935-943. doi: 10.31557/APJCP.2023.24.3.935.

DOI:10.31557/APJCP.2023.24.3.935
PMID:36974548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10334080/
Abstract

BACKGROUND

Seropositivity to certain Helicobacter pylori proteins may affect development of gastric lesions that could become cancerous. Previously, we developed a model of gastric cancer risk including gender, age, HP0305 sero-positivity, HP1564 sero-positivity, UreA antibody titer and serologically defined chronic atrophic gastritis (termed: "Lasso model").

METHODS

We evaluated the Lasso model's ability to discriminate individuals with precancerous gastric lesions (n=320) from individuals with superficial or mild atrophic gastritis (n=226) in Linqu County, China, a population at high risk for gastric cancer. We also compared its performance to the ABC Method, a gastric cancer risk stratification tool currently used in East Asia.

RESULTS

For distinguishing precancerous lesions from those with gastritis, the receiver operating characteristic curve had an area under the curve (AUC) of 73.41% (95% CI: 69.10%, 77.71%) and, at Youden's Index, a sensitivity of 78.44% (59.38%, 82.50%) and specificity of 64.72% (95% CI: 58.85%, 81.42%). Positive predictive value (PPV) was 75.38% (72.78%, 82.51%). Specificity, AUC and PPV were significantly greater (p < 0.05) than those of the ABC Method. When specificity was held constant, the Lasso model had greater sensitivity, PPV and negative predictive value (NPV) than the ABC Method. However, adjusting the ABC Method for age and gender negated the Lasso model's significant improvement in AUC.

CONCLUSIONS

The Lasso model for gastric cancer risk prediction can classify precancerous lesions with significantly greater AUC than the ABC Method and, at constant specificity, with greater sensitivity, PPV and NPV. However, adding age and gender to the ABC Method, as included in the Lasso model, substantially improved its performance and negated the Lasso model's advantage.

摘要

背景

某些幽门螺杆菌蛋白的血清阳性可能会影响发展为可能癌变的胃部病变。此前,我们开发了一种包括性别、年龄、HP0305 血清阳性、HP1564 血清阳性、UreA 抗体滴度和血清学定义的慢性萎缩性胃炎的胃癌风险模型(称为“lasso 模型”)。

方法

我们评估了 lasso 模型在中国林曲县(胃癌高危人群)从患有癌前胃病变的个体(n=320)和患有浅表或轻度萎缩性胃炎的个体(n=226)中区分癌前病变的能力。我们还比较了它与 ABC 方法(目前在东亚使用的胃癌风险分层工具)的性能。

结果

在区分癌前病变和胃炎方面,受试者工作特征曲线下面积(AUC)为 73.41%(95%CI:69.10%,77.71%),在尤登指数下,敏感性为 78.44%(59.38%,82.50%),特异性为 64.72%(95%CI:58.85%,81.42%)。阳性预测值(PPV)为 75.38%(72.78%,82.51%)。特异性、AUC 和 PPV均显著高于 ABC 方法(p<0.05)。当特异性保持不变时,lasso 模型的敏感性、PPV 和阴性预测值(NPV)均高于 ABC 方法。然而,调整 ABC 方法以适应年龄和性别,否定了 lasso 模型在 AUC 方面的显著改善。

结论

与 ABC 方法相比,lasso 模型在预测胃癌风险方面,分类癌前病变的 AUC 显著提高,在保持特异性的情况下,敏感性、PPV 和 NPV均提高。然而,在 ABC 方法中加入年龄和性别,就像 lasso 模型所包含的那样,大大提高了它的性能,并否定了 lasso 模型的优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b5/10334080/9f2bcb3d54fe/APJCP-24-935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b5/10334080/9f2bcb3d54fe/APJCP-24-935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b5/10334080/9f2bcb3d54fe/APJCP-24-935-g001.jpg

相似文献

1
Discrimination between Precancerous Gastric Lesions and Gastritis Using a Gastric Cancer Risk Stratification Model.基于胃癌风险分层模型鉴别癌前病变与胃炎
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):935-943. doi: 10.31557/APJCP.2023.24.3.935.
2
Gastric mucosal precancerous lesions in -infected pediatric patients in central China: A single-center, retrospective investigation.中国中部感染幽门螺杆菌的儿科患者的胃黏膜癌前病变:一项单中心回顾性研究。
World J Gastroenterol. 2022 Jul 28;28(28):3682-3694. doi: 10.3748/wjg.v28.i28.3682.
3
The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.新型胃癌筛查评分系统在中国胃癌筛查及癌前病变风险评估中的应用
Scand J Gastroenterol. 2023 Jan;58(1):34-37. doi: 10.1080/00365521.2022.2099761. Epub 2022 Jul 22.
4
[A comparative study of new gastric cancer screening scoring system and new ABC method for screening gastric cancer and precancerous lesions].新型胃癌筛查评分系统与新型ABC法筛查胃癌及癌前病变的对比研究
Zhonghua Nei Ke Za Zhi. 2021 Mar 1;60(3):227-232. doi: 10.3760/cma.j.cn112138-20200512-00476.
5
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.基于抗幽门螺杆菌蛋白和胃蛋白酶原抗体反应的非贲门胃腺癌风险预测模型。
Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):811-820. doi: 10.1158/1055-9965.EPI-21-0869.
6
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.中国高危人群中幽门螺杆菌抗体与胃癌前病变的关系
Cancer Epidemiol Biomarkers Prev. 1996 Aug;5(8):627-30.
7
Helicobacter pylori and precancerous conditions of the stomach: the frequency of infection in a cross-sectional study of 79 consecutive patients with chronic antral gastritis in Yaoundé, Cameroon.幽门螺杆菌与胃的癌前病变:喀麦隆雅温得79例连续性慢性胃窦炎患者横断面研究中的感染率
Pan Afr Med J. 2015 Jan 20;20:52. doi: 10.11604/pamj.2015.20.52.5887. eCollection 2015.
8
[Precancerous conditions and lesions of the stomach].[胃的癌前状况和病变]
Klin Onkol. 2013;26 Suppl:S22-8. doi: 10.14735/amko2013s22.
9
Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.完整胃中的幽门螺杆菌胃炎及切除胃中的胃炎中的癌前病变。
J Exp Clin Cancer Res. 2003 Sep;22(3):371-8.
10
Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study.癌前胃病变中与幽门螺杆菌感染相关的p16启动子甲基化:一项基于人群的研究。
Int J Cancer. 2009 Jan 15;124(2):434-9. doi: 10.1002/ijc.23891.

本文引用的文献

1
A Predictive Model of Noncardia Gastric Adenocarcinoma Risk Using Antibody Response to Helicobacter pylori Proteins and Pepsinogen.基于抗幽门螺杆菌蛋白和胃蛋白酶原抗体反应的非贲门胃腺癌风险预测模型。
Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):811-820. doi: 10.1158/1055-9965.EPI-21-0869.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
How to Read Articles That Use Machine Learning: Users' Guides to the Medical Literature.
如何阅读使用机器学习的文章:医学文献的用户指南。
JAMA. 2019 Nov 12;322(18):1806-1816. doi: 10.1001/jama.2019.16489.
4
Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis.幽门螺杆菌根除对胃癌发病率的影响:系统评价和荟萃分析。
Gastric Cancer. 2019 May;22(3):435-445. doi: 10.1007/s10120-018-0876-0. Epub 2018 Sep 11.
5
Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer.血液生物标志物用于鉴定胃癌高危个体的验证。
Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1472-1479. doi: 10.1158/1055-9965.EPI-18-0582. Epub 2018 Aug 29.
6
Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies.根除幽门螺杆菌与胃癌:队列研究的系统评价和荟萃分析。
J Natl Cancer Inst. 2016 Jul 14;108(9). doi: 10.1093/jnci/djw132. Print 2016 Sep.
7
Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.东亚地区胃癌风险的幽门螺杆菌血液生物标志物
Int J Epidemiol. 2016 Jun;45(3):774-81. doi: 10.1093/ije/dyw078. Epub 2016 May 11.
8
Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.通过联合检测血清抗幽门螺杆菌IgG抗体和血清胃蛋白酶原水平进行胃癌筛查——ABC法
Digestion. 2016;93(1):13-8. doi: 10.1159/000441742. Epub 2016 Jan 14.
9
Global patterns of cardia and non-cardia gastric cancer incidence in 2012.2012 年全球贲门和非贲门胃癌发病率模式。
Gut. 2015 Dec;64(12):1881-8. doi: 10.1136/gutjnl-2014-308915. Epub 2015 Mar 6.
10
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.